Liquidia Investment Portfolios

Liquidia Corporation Expands Partnership with Pharmosa Biopharm to Advance Inhaled Treprostinil Therapy Oct 3, 2024

Court Rules Against United Therapeutics, Awards Over $137 Million to Liquidia Corp for Generic Drug Launch Delays Sep 16, 2024

Liquidia Corporation to Announce Full Year 2023 Financial Performance Mar 6, 2024

Liquidia Corporation Sets Public Offering Price of Common Stock Dec 12, 2023